Avyxa Pharma

DOCIVYX

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

Avyxa Pharma

Docivyx HCPCS:

J9172

J9172 Effective Date:

January 1, 2024

J9172 Added Date:

January 1, 2024

HCPCS Code Descriptor:

Injection, docetaxel (ingenus), not therapeutically equivalent to j9171, 1 mg

Category:

J Code

Docivyx NDCs:

83831-0102-08, 83831-0103-16, 83831-0101-02

Primary Type:

Oncology

Generic/Specialty Status:

Single-Source

Package Type:

Not Found

Route of Administration:

Intravenous

Docetaxel CPT Codes:

Potential CPT administration codes for Docetaxel can be found at the following link.

Potential NDC Listing Errors:

We have not identified any potential errors with the NDCs mapped to this HCPCS code.

About Docetaxel:

DOCIVYX is a Oncology drug manufactured by Avyxa Pharma and administered via the intravenous route of administration. The J Code: J9172 is aligned to the drug DOCIVYX.

The Docivyx billing and coding guide is published by Avyxa pharma and is available at the link below:
Visit the Docivyx reimbursement support page for patient assistance information at the link below:
DOCIVYX prescribing information can be found at the link below:
Information regarding DOCIVYX side effects can be found at MedlinePlus

BuyandBill.com Drug Alert: